Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma

J Clin Oncol. 2008 May 20;26(15):2584-6. doi: 10.1200/JCO.2007.15.4807.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / adverse effects*
  • Head and Neck Neoplasms / diagnostic imaging
  • Head and Neck Neoplasms / drug therapy*
  • Hepacivirus / physiology*
  • Hepatitis C / virology*
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / diagnostic imaging
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male
  • Positron-Emission Tomography
  • RNA, Viral / analysis
  • Rituximab
  • Tomography, X-Ray Computed
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • RNA, Viral
  • Rituximab